Search

everythinglearnresearchcommunity

for

Search:↓

The new compound is a promising, less toxic alternative to finasteride for treating prostate issues.

Sorafenib can cause a unique skin reaction.

Researchers found several compounds that could potentially treat Zika virus.

A new treatment called deucravacitinib helped a patient with severe hair loss grow their hair back quickly.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

The treatment cleared psoriasis in some patients but caused side effects in most.

Taking 5-alpha reductase inhibitors might be linked to breast cancer in men.

All four treatments for early rheumatoid arthritis had similar safety profiles.

Oral tacrolimus helped a rheumatoid arthritis patient regrow hair lost due to alopecia areata.

The man's rash, hair loss, and vision issues were due to syphilis, not CMV.

HVDRR is caused by VDR gene mutations, leading to vitamin D resistance, treatable with high calcium doses, but alopecia remains permanent.

The combination treatment showed a higher response rate but no significant survival benefits.

Renal transplant recipients often have skin issues, especially infections, and need regular skin check-ups.

Men taking dutasteride may have a higher risk of age-related macular degeneration.

Proretinal nanoparticles are a safe and effective way to deliver retinal to the skin.

Abrocitinib, a JAK inhibitor, may help treat atopic dermatitis and alopecia universalis together.

Dabrafenib was effective and well tolerated in treating thyroid cancer with a specific mutation.

5-alpha-reductase inhibitors might help slow down low-risk prostate cancer, but their use should be cautious.

Ethanamizuril is safe for rats at 20 mg/kg feed, but higher doses cause hair loss, organ changes, and liver, kidney, and lung damage.

RU58841 significantly increases hair growth rate and initiates more hair cycles, but doesn't affect hair thickness, suggesting it could be a new treatment for baldness.

A woman's vitiligo improved with tofacitinib treatment, and her skin color remained even after stopping the medication, but there are concerns about cancer risk.

CI-1033 causes skin lesions in rats, similar to humans, due to EGF receptor inhibition.

Rituximab may cause skin issues, but baricitinib can help improve them.

RXRa is crucial for Th2 immune cell development and may link nutrition to immune health.

A new drug, abrocitinib, helped a child with severe hair loss regrow hair.

Oral ritlecitinib and baricitinib are promising treatments for severe alopecia areata due to their balance of effectiveness and safety.